Latest Regenerative December 31, 2025 News

Japan’s SAKIGAKE designation may help accelerate development and review of the embryonic stem cell-derived therapy.
A court ordered major penalties and reimbursements after deceptive stem cell treatments were marketed to Iowans, particularly older residents.
The new clinic will offer stem cell therapies, AI-guided health management, and combine Eastern and Western medical approaches, along with developing new immunotherapies and iPSCs.
The Phase II trial showed significant motor function improvements and safety for an allogeneic stem cell therapy in Parkinson’s disease.

Stay updated on Regenerative Medicine